[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Arteris, Inc. reported a Form 144 notice showing an intended sale of 19,060 shares of its common stock by a holder using Morgan Stanley Smith Barney LLC as broker, with an aggregate market value of $200,130.00. The filing states the shares were acquired as Restricted Stock Units on 09/03/2024 and the planned approximate sale date is 10/02/2025 on NASDAQ. The issuer has 42,649,917 shares outstanding per the filing. The notice also lists multiple recent sales by the same person under a 10b5-1 plan and direct sales between 07/03/2025 and 09/09/2025, totaling tens of thousands of shares and several hundred thousand dollars in gross proceeds.

Positive

• Securities were acquired as Restricted Stock Units, indicating standard equity compensation rather than insider purchases
• Planned sale is modest relative to outstanding shares (19,060 vs 42,649,917 outstanding)

Negative

• Recent selling activity under a 10b5-1 plan and direct sales includes larger totals (e.g., 34,400 shares on 08/05/2025), which may reflect notable insider disposition
• Form 144 records multiple sales over the past months with aggregate gross proceeds in the hundreds of thousands of dollars

Insights

Insider Transactions Analyst

TL;DR: An insider intends to sell 19,060 RSU-derived shares worth $200,130; recent 10b5-1 and direct sales are listed.

The Form 144 shows the securities to be sold were acquired as Restricted Stock Units on 09/03/2024, indicating the holder is disposing of recently vested equity rather than long-held stock.

The filing records several sales executed under a 10b5-1 plan and one direct sale between 07/03/2025 and 09/09/2025, with individual gross proceeds reported (for example, $466,763.28 on 08/05/2025).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19060	200130.00	42649917	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/03/2024	Restricted Stock Units	Issuer			19060	09/03/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/09/2025	151	1300.11
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/08/2025	8129	71075.10
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/05/2025	4698	41363.54
LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	42692	381739.06
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	34400	466763.28
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/29/2025	736	8022.40
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/03/2025	1554	14342.21

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arteris (AIP) Form 144 report?

The Form 144 reports an intended sale of 19,060 common shares valued at $200,130.00, to be sold approximately on 10/02/2025 on NASDAQ.

How were the shares being sold acquired for AIP?

The shares were acquired as Restricted Stock Units on 09/03/2024 and the filing lists the acquisition date as 09/03/2024.

Who is the broker handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York.

Does the filing show prior sales by the same person?

Yes. The filing lists multiple prior sales under a 10b5-1 plan and one direct sale between 07/03/2025 and 09/09/2025, with gross proceeds reported for each transaction.

How many AIP shares are outstanding per the filing?

The filing reports 42,649,917 shares outstanding.